ZJAMP Group Co., Ltd. (002758.SZ)
CNY 9.38
(-1.99%)
CNY 9.38
(-1.99%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 2.88 Billion CNY | -4.9% |
| 2022 | 3.03 Billion CNY | 18.07% |
| 2021 | 2.57 Billion CNY | 89.91% |
| 2020 | 1.35 Billion CNY | 171.08% |
| 2019 | 499.45 Million CNY | 2.45% |
| 2018 | 487.53 Million CNY | 77.84% |
| 2017 | 274.14 Million CNY | 161.09% |
| 2016 | 105 Million CNY | 76.47% |
| 2015 | 59.5 Million CNY | -53.52% |
| 2014 | 128 Million CNY | -16.34% |
| 2013 | 153 Million CNY | 3.38% |
| 2012 | 148 Million CNY | 11.28% |
| 2011 | 133 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 1.78 Billion CNY | -33.05% |
| 2024 Q1 | 3.57 Billion CNY | 23.67% |
| 2024 Q2 | 3.29 Billion CNY | -7.73% |
| 2023 Q2 | 3.53 Billion CNY | 19.18% |
| 2023 Q4 | 2.88 Billion CNY | -8.4% |
| 2023 FY | 2.88 Billion CNY | -4.9% |
| 2023 Q1 | 2.96 Billion CNY | -2.43% |
| 2023 Q3 | 3.15 Billion CNY | -10.71% |
| 2022 FY | 3.03 Billion CNY | 18.07% |
| 2022 Q3 | 3.1 Billion CNY | -7.78% |
| 2022 Q1 | 2.82 Billion CNY | 9.86% |
| 2022 Q4 | 3.03 Billion CNY | -2.15% |
| 2022 Q2 | 3.36 Billion CNY | 19.1% |
| 2021 Q2 | 2.12 Billion CNY | 7.67% |
| 2021 FY | 2.57 Billion CNY | 89.91% |
| 2021 Q3 | 2.03 Billion CNY | -4.12% |
| 2021 Q1 | 1.97 Billion CNY | 45.96% |
| 2021 Q4 | 2.57 Billion CNY | 26.04% |
| 2020 Q4 | 1.35 Billion CNY | 252.71% |
| 2020 Q1 | 507.13 Million CNY | 1.54% |
| 2020 FY | 1.35 Billion CNY | 171.08% |
| 2020 Q2 | 425.84 Million CNY | -16.03% |
| 2020 Q3 | 383.86 Million CNY | -9.86% |
| 2019 Q3 | 505.72 Million CNY | -1.37% |
| 2019 FY | 499.45 Million CNY | 2.45% |
| 2019 Q4 | 499.45 Million CNY | -1.24% |
| 2019 Q2 | 512.76 Million CNY | 0.38% |
| 2019 Q1 | 510.84 Million CNY | 4.78% |
| 2018 FY | 487.53 Million CNY | 77.84% |
| 2018 Q4 | 487.53 Million CNY | 0.81% |
| 2018 Q1 | 314.14 Million CNY | 14.59% |
| 2018 Q2 | 491.15 Million CNY | 56.35% |
| 2018 Q3 | 483.59 Million CNY | -1.54% |
| 2017 Q3 | 250.55 Million CNY | -1.76% |
| 2017 Q4 | 274.14 Million CNY | 9.42% |
| 2017 FY | 274.14 Million CNY | 161.09% |
| 2017 Q2 | 255.05 Million CNY | 30.13% |
| 2017 Q1 | 196 Million CNY | 86.67% |
| 2016 Q1 | 74.5 Million CNY | 25.21% |
| 2016 Q4 | 105 Million CNY | 23.53% |
| 2016 Q3 | 85 Million CNY | 0.0% |
| 2016 Q2 | 85 Million CNY | 14.09% |
| 2016 FY | 105 Million CNY | 76.47% |
| 2015 FY | 59.5 Million CNY | -53.52% |
| 2015 Q4 | 59.5 Million CNY | 48.75% |
| 2015 Q3 | 40 Million CNY | -45.21% |
| 2015 Q2 | 73 Million CNY | -38.14% |
| 2015 Q1 | 118 Million CNY | -7.81% |
| 2014 Q4 | 128 Million CNY | 0.0% |
| 2014 FY | 128 Million CNY | -16.34% |
| 2013 FY | 153 Million CNY | 3.38% |
| 2012 FY | 148 Million CNY | 11.28% |
| 2011 FY | 133 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Cachet Pharmaceutical Co., Ltd. | 4.01 Billion CNY | 28.153% |
| Yixintang Pharmaceutical Group Co., Ltd. | 4.88 Billion CNY | 40.908% |
| Luyan Pharma Co.,Ltd. | 4.84 Billion CNY | 40.349% |
| Ji Yao Holding Group Co., Ltd. | 1.44 Billion CNY | -99.333% |